Webinar – Accelerating Drug Target Identification and Characterization

In early drug discovery, the speed at which you can validate a target often defines the success of a program. Join Dr. Judith Ronau, Senior Scientist at AbbVie, as she details how her team utilizes cell-free protein expression to eliminate the bottlenecks of traditional cell-based production.

Nuclera is attending NextGen Biomed 2026 in March at the QEII Centre, London. Find out more about eProtein Discovery™ Cell Free Protein Expression.

Nuclera is attending The Association of Biomolecular Resource Facilities (ABRF) at the David L. Lawrence Convention Center, March 28-31, 2026. Find out more about eProtein Discovery™ Cell Free Protein Expression.